Fakultni nemocnice v Motole ( Site 0700)

Prague 150 06

1 studies enrolling now · 2 studies all time

What they study most

Hematologic Malignancies, Heterozygous Familial Hypercholesterolemia (HeFH), Solid Tumors

Studies at this site

• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) — Recruiting now
• Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) — Recruiting now